Victorian Government, Johnson & Johnson Innovation and Monash partnership extended
An innovative Andrews Labor Government partnership with industry and academia has been extended, with Victorian medical researchers and early-stage medtech entrepreneurs producing results that are changing lives.
Monash awarded $2 million to investigate embedding pharmacists in residential aged care facilities
Monash University’s Centre for Medicine Use and Safety (CMUS) has been awarded $2 million through the Medical Research Future Fund (MRFF) to investigate embedding pharmacists in residential aged care facilities.
MIPS researchers receive MRFF funding to accelerate discovery research projects
Researchers from the Monash Institute of Pharmaceutical Sciences (MIPS) are leading, or playing an integral role, in a number of projects which have received funding from the Commonwealth Government’s Medical Research Future Fund (MRFF).
Monash receives $5m grant to make COVID-19 mRNA vaccine for clinical trials
Monash University has received $5 million from the Victorian Government to manufacture the first Australian batch of a COVID-19 mRNA vaccine for clinical trials, using a vaccine candidate developed by researchers from the Monash Institute of
Next-gen antibiotic developed by Monash University enters clinical trials
In a critical step towards addressing an urgent unmet medical need due to infections caused by antibiotic-resistant bacteria - also known as ‘superbugs’ - a new antibiotic (QPX9003) discovered by Monash University researchers has entered
Monash University drug researchers discover potent class of molecules that kills malaria parasite
A world-leading team of antimalarial researchers from the Monash Institute of Pharmaceutical Sciences (MIPS) have discovered a new class of molecules capable of killing Plasmodium falciparum, the parasite that causes malaria in humans through the
MIPS researcher awarded for knowledge commercialisation
Professor Jonathan Baell and colleagues from WEHI were recognised for their work in developing a new cancer treatment.
New research highlights potential overtreatment and undertreatment of diabetes in residential aged care
A new international study led by Monash University has found that residents with type 2 diabetes in residential aged care are potentially being overtreated – or missing out on treatment altogether.
Scientists develop novel tools to gain new insights into an important therapeutic target
A team of researchers, led by the Monash Institute of Pharmaceutical Sciences (MIPS) have, for the first time, developed a tool that will enable the wider scientific community to gain a deeper understanding of how the human adenosine A1 receptor